SCHEMBL154857

SCHEMBL154857

CC(C)(O)C(=O)c1ccc(CCO)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP4A11 Q02928 7/20 0.50
▸ CYP4F2 P78329 6/20 0.50
▸ PPARA Q07869 2/20 0.49
▸ CA2 P00918 3/20 0.43
▸ CA1 P00915 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ CA5B Q9Y2D0 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ PLK1 P53350 1/20 0.38
▸ PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Monoethanolamine SCHEMBL3973136 0.93 CYP4A11 (0.45) CYP4A11CYP4F2PPARACA2CA1
SCHEMBL3687860 0.90 PLK1 (0.41) CYP4A11CA2PLK1
SCHEMBL9808693 0.89 CYP4A11 (0.57) CYP4A11CYP4F2PPARACA2PLK1
SCHEMBL28584026 0.85 CYP4A11 (0.47) CYP4A11CYP4F2PPARACA2CA1
SCHEMBL1060928 0.85 PLK1 (0.55) TDP1PLK1
SCHEMBL480503 0.84 EPHX2 (0.49) PPARACA2CA1CA12CA4
SCHEMBL9808692 0.83 TAAR1 (0.45) CA2CA1TDP1CA12CA4
SCHEMBL3976669 0.83 KMT2A (0.47) CYP4A11TDP1PLK1
SCHEMBL153898 0.82 KMT2A (0.56) CA2PLK1
SCHEMBL195630 0.81 RARB (0.57) PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 471 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250262146-A1 PLATFORM NANOPARTICLE TECHNOLOGY FOR SUSTAINED DELIVERY OF HYDROPHOBIC DRUGS UNIVERSITY OF MARYLAND, BALTIMORE 2025-08-21 — — US claimed
EP-4514395-A1 PLATFORM NANOPARTICLE TECHNOLOGY FOR SUSTAINED DELIVERY OF HYDROPHOBIC DRUGS University of Maryland, Baltimore (US) 2025-03-05 — — EP claimed
CN-117799197-A Large-area electrochromic device and preparation method thereof 绍兴百立盛新材料科技有限公司 2024-04-02 — — CN claimed
WO-2023212047-A1 PLATFORM NANOPARTICLE TECHNOLOGY FOR SUSTAINED DELIVERY OF HYDROPHOBIC DRUGS UNIVERSITY OF MARYLAND, BALTIMORE (US) 2023-11-02 — — WO claimed
CN-114752210-A Ultraviolet curing electrolyte, preparation method of electrolyte membrane and electrochromic device 江苏慧智新材料科技有限公司 2022-07-15 — — CN claimed
US-6316519-B1 CONTACTING MONOETHYLENICALLY UNSATURATED MONOMER WITH PHOTOINITIATOR; CONTACTING WITH ACTINIC RADIATION IN A PHOTOREACTOR, AND FORMING A LINEAR POLYMER OF CONTROLLED MOLECULAR WEIGHT E. I. DU PONT DE NEMOURS AND COMPANY 2001-11-13 — — US claimed
EP-0216884-B1 PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS MERCK PATENT GmbH (DE) 1990-08-08 — — EP claimed
EP-0216884-A1 PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS. MERCK PATENT GMBH (DE) 1987-04-08 — — EP claimed
WO-1986005777-A1 PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1986-10-09 — — WO claimed
WO-1986005778-A1 PHOTO-INITIATORS FOR PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1986-10-09 — — WO claimed
JP-6228218-A — — None — — JP disclosed
CN-122080333-A Curable composition, heat storage material, and article — 2026-05-26 — — CN disclosed
WO-2026105802-A1 RESIN COMPOSITION, DRY FILM, AND CURED PRODUCT 太陽ホールディングス株式会社 2026-05-21 — — WO disclosed
CN-122070344-A Pressure-sensitive adhesive composition, pressure-sensitive adhesive sheet, and joined body 日东电工株式会社 2026-05-19 — — CN disclosed
CN-122011299-A Curable composition, heat storage material, and article 株式会社力森诺科 2026-05-12 — — CN disclosed
EP-0216884-B1 PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS MERCK PATENT GmbH (DE) 1990-08-08 — — EP disclosed
US-4861916-A Photoinitiators for photopolymerization of unsaturated systems MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1989-08-29 — — US disclosed
EP-0216884-A1 PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS. MERCK PATENT GMBH (DE) 1987-04-08 — — EP disclosed
WO-1986005777-A1 PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1986-10-09 — — WO disclosed
WO-1986005778-A1 PHOTO-INITIATORS FOR PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1986-10-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250262146-A1 PLATFORM NANOPARTICLE TECHNOLOGY FOR SUSTAINED DELIVERY OF HYDROPHOBIC DRUGS VEGFA, LDHA, LDHB CYP4A11 4137/4885CYP4F2 2871/4885PPARA 2977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback